7.75

2.65% 0.20

After Hours: 7.92 0.17 +2.19%

Lenz Therapeutics Inc (LENZ)

Overview News Price History Discussions Forecast

Lenz Therapeutics Inc stock is traded at $7.75, with a volume of 709.79K. It is up +2.65% in the last 24 hours and down -17.38% over the past month. LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

Previous Close:

$7.55

Open:

$7.62

24h Volume:

709.79K

Relative Volume:

0.77

Market Cap:

$243.00M

Revenue:

$19.09M

Net Income/Loss:

$-82.13M

P/E Ratio:

-2.7653

EPS:

-2.8026

Net Cash Flow:

$-70.00M

1W Performance:

+16.54%

1M Performance:

-17.38%

6M Performance:

-74.77%

1Y Performance:

-72.49%

1-Day Range:

$7.56

$7.91

1-Week Range:

$6.66

$7.91

52-Week Range:

$6.61

$50.40

Lenz Therapeutics Inc Stock (LENZ) Company Profile

Name

Lenz Therapeutics Inc

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

858-925-7000

Address

201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH

Employee

152

Twitter

Next Earnings Date

2026-05-11

Latest SEC Filings

LENZ's Discussions on Twitter

Compare LENZ vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LENZ Lenz Therapeutics Inc	7.75	236.73M	19.09M	-82.13M	-70.00M	-2.8026
VRTX Vertex Pharmaceuticals Inc	435.93	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.62	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.43	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-14-25	Resumed	Piper Sandler	Overweight
Mar-18-25	Initiated	TD Cowen	Buy
Sep-27-24	Initiated	Raymond James	Outperform
Aug-12-24	Initiated	H.C. Wainwright	Buy
Apr-15-24	Initiated	Leerink Partners	Outperform
Apr-15-24	Initiated	William Blair	Outperform
Apr-10-24	Initiated	Citigroup	Buy
Mar-27-24	Initiated	Piper Sandler	Overweight
Feb-23-23	Downgrade	BofA Securities	Neutral → Underperform
Feb-23-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Feb-23-23	Downgrade	Cowen	Outperform → Market Perform
Jan-25-23	Downgrade	BTIG Research	Buy → Neutral
Jan-18-23	Downgrade	BofA Securities	Buy → Neutral
Jan-06-23	Downgrade	BMO Capital Markets	Outperform → Market Perform
Jan-06-23	Downgrade	SVB Leerink	Outperform → Mkt Perform
Sep-15-22	Initiated	Cantor Fitzgerald	Overweight
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Apr-14-22	Initiated	BTIG Research	Buy
Mar-22-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Feb-18-22	Initiated	RBC Capital Mkts	Sector Perform
Jul-20-21	Initiated	Morgan Stanley	Overweight
Jul-20-21	Initiated	SVB Leerink	Outperform

View All

Lenz Therapeutics Inc Stock (LENZ) Latest News

08:36 AM

Eye drop company LENZ heads to three investor conferences in June - Stock Titan

08:36 AM

08:00 AM

LENZ Therapeutics to Participate in Upcoming Investor Conferences - Yahoo Finance

08:00 AM

May 19, 2026

Earnings call transcript: LENZ Therapeutics sees growth in Q1 2026 By Investing.com - Investing.com Nigeria

May 19, 2026

May 18, 2026

Industry Analysts Just Made A Stunning Upgrade To Their Maze Therapeutics, Inc. (NASDAQ:MAZE) Revenue Forecasts - Yahoo Finance

May 17, 2026

LENZ Therapeutics Q1 2026 earnings preview - MSN

May 17, 2026

May 16, 2026

Some LENZ Therapeutics, Inc. (NASDAQ:LENZ) Analysts Just Made A Major Cut To Next Year's Estimates - simplywall.st

May 16, 2026

Things Look Grim For LENZ Therapeutics, Inc. (NASDAQ:LENZ) After Today's Downgrade - Yahoo Finance

May 16, 2026

May 15, 2026

Earnings Update: LENZ Therapeutics, Inc. (NASDAQ:LENZ) Just Reported And Analysts Are Trimming Their Forecasts - Sahm

May 15, 2026

LENZ Stock Price, Quote & Chart | LENZ THERAPEUTICS INC (NASDAQ:LENZ) - ChartMill

May 15, 2026

May 14, 2026

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Moomoo

May 14, 2026

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance

May 14, 2026

May 13, 2026